Publications by authors named "Gilca Vladimir"

Claim this Profile
L
Long term immunogenicity of two doses of the quadrivalent HPV vaccine and the effect of an additional dose given five years post-primary vaccination.
Chantal Sauvageau, Iulia Gabriela Ionescu, Manale Ouakki, Gitika Panicker, Elizabeth R Unger, Vladimir Gilca

Vaccine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune memory assessment three years following a single dose of hepatitis a vaccine at 12, 13 or 19 months of age.
Yossi Febriani, Marie-Michelle Ursu, Chantal Sauvageau, Koffi Barnabé Kegbevi, Caroline Quach, Vladimir Gilca

Vaccine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection Against Persistent HPV-16/18 Infection After Different Number of Doses of Quadrivalent Vaccine in Girls and Young Women: A Randomized Clinical Trial.
Chantal Sauvageau, Marie-Hélène Mayrand, Manale Ouakki, Iulia Gabriela Ionescu, François Coutlée, Vladimir Gilca

JAMA Netw Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.
Sara Carazo, Danuta M Skowronski, Marc Brisson, Sapha Barkati, Chantal Sauvageau, Vladimir Gilca

Lancet Infect Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuing Medical Education Improves Physician Communication Skills and Increases Likelihood of Pediatric Vaccination: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)-II.
William A Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield

Vaccines (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine.
Sabryna Nantel, Benoîte Bourdin, Kelsey Adams, Julie Carbonneau, Henintsoa Rabezanahary, Vladimir Gilca

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of influenza on the ability to work, volunteer and provide care: results from an online survey of Canadian adults 50 years and older.
Nancy M Waite, Jennifer A Pereira, Sherilyn K D Houle, Vladimir Gilca, Melissa K Andrew

BMC Public Health· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicians Are Not Able to Infer Parental Intentions to Vaccinate Infants with a Seasonal Influenza Vaccine, and Perhaps They Should Not Try: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)-IV.
William A Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parental Attitudes and Perceptions of Support after Brief Clinician Intervention Predict Intentions to Accept the Adjuvanted Seasonal Influenza Vaccination: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)-I.
William A Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.
Sara Carazo, Danuta M Skowronski, Marc Brisson, Chantal Sauvageau, Nicholas Brousseau, Vladimir Gilca

JAMA Netw Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Impact of Approved but Unfunded Vaccine Status on Parental Acceptance of an Adjuvanted Seasonal Influenza Vaccine for Infants: Results from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)-III.
William A Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield

Vaccines (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers.
Étienne Racine, Guy Boivin, Yves Longtin, Deirdre McCormack, Hélène Decaluwe, Vladimir Gilca

Influenza Other Respir Viruses· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women.
Chantal Sauvageau, Vladimir Gilca, Manale Ouakki, Marilou Kiely, François Coutlée

Hum Vaccin Immunother· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19's Impact on Willingness to Be Vaccinated against Influenza and COVID-19 during the 2020/2021 Season: Results from an Online Survey of Canadian Adults 50 Years and Older.
Nancy M Waite, Jennifer A Pereira, Sherilyn K D Houle, Vladimir Gilca, Melissa K Andrew

Vaccines (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic literature review of the recombinant subunit herpes zoster vaccine use in immunocompromised 18-49 year old patients.
Étienne Racine, Vladimir Gilca, Rachid Amini, Matthew Tunis, Shainoor Ismail

Vaccine· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.
Robine Donken, Simon R M Dobson, Kim D Marty, Darrel Cook, Chantal Sauvageau, Vladimir Gilca

Clin Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long intervals between two doses of HPV vaccines and magnitude of the immune response: a analysis of two clinical trials.
Vladimir Gilca, Chantal Sauvageau, Gitika Panicker, Gaston De Serres, John Schiller

Hum Vaccin Immunother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials.
Chantal Sauvageau, Gitika Panicker, Elizabeth R Unger, Gaston De Serres, John Schiller, Vladimir Gilca

Hum Vaccin Immunother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immune response to a two-dose schedule of quadrivalent HPV vaccine in 9-13 year-old girls: Is it influenced by age, menarche status or body mass index?
Chantal Sauvageau, Vladimir Gilca, Robine Donken, Shu Yu Fan, Gina Ogilvie

Vaccine· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study.
Mélanie Drolet, Zhou Zhou, Chantal Sauvageau, Philippe DeWals, Vladimir Gilca

CMAJ· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine.
Vladimir Gilca, Chantal Sauvageau, Gaston De Serres

Vaccine· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXamining the knowledge, Attitudes and experiences of Canadian seniors Towards influenza (the EXACT survey).
Melissa K Andrew, Vladimir Gilca, Nancy Waite, Jennifer A Pereira

BMC Geriatr· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada.
Gaston De Serres, Marie-Noëlle Billard, Marie-Claude Gariépy, Isabelle Rouleau, Eveline Toth, Vladimir Gilca

Vaccine· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.
Vladimir Gilca, Chantal Sauvageau, Gitika Panicker, Gaston De Serres, Manale Ouakki

Vaccine· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpes Zoster Burden in Canadian Provinces: A Narrative Review and Comparison with Quebec Provincial Data.
Marie-Claude Letellier, Rachid Amini, Vladimir Gilca, Gisele Trudeau, Chantal Sauvageau

Can J Infect Dis Med Microbiol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis